Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
Submitted by
admin
on February 10, 2016 - 10:30am
Source:
Bizjournals.com
News Tags:
ARMO BioSciences
venture capital
Alphabet
Celgene
cancer immunotherapy
Headline:
With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
Do Not Allow Advertisers to Use My Personal information
